2002•Academic Journal of Second Military Medical UniversityRequires access

Epidermal growth factor prevents bacterial translocation in rats with acute pancreatitis

Dong Chen

Open publisher page 0 citations

Abstract

Objective: To evaluate the protective effect of epidermal growth factor (EGF) on intestinal barrier functionin rats with acute pancreatitis. Methods: Thirty-two male SD rats received injection of sodium taurocholate solution(3. 5 mg·L-1) into the pancreatic duct were randomly divided into control group (n=16) and treatment group (n=16). Animals incontrol group received total parenteral nutrition (TPN), animals in treatment group were fed on the same TPN formula ascontrol group and injections of EGF at a dose of 0. 2 mg' kg l' day--'. Rats were sacrificed on d 1 and d 5 of TPN. Concen-tration of xylose and fluorescein isothiocyanate (FITC)-dextran in superior mesenteric vein (SMV), protein and DNA contentin je junal mucosa were determined. Samples from SMV, mesenteric lymph nodes, pancreas, liver, spleen were harvested forcultures. Results: FITC-dextran concentration in treatment group was significantly lower than in control group [(3. 4±0. 7)vs (7. 5±0. 9) mg. L-1, P<0. 0l]. Protein and DNA content in je junal mucosa in treatment group were significantly higherthan in control group [(2. 65±0. 23) vs (1. 12±0. 18) mg· cm-1, (0. 25±0. 07) vs (0. 12±0. 04) mg·cm-1, P0. 01].Positive cultures in liver and spleen in treatment group were significantly lower than in control group (37.5 % vs 100%, 25%vs 100%, P0.05). Conclusion: EGF may prevent the increase of intestinal permeability and bacterial translocation duringTPN in rats with acute pancreatitis.

About this research paper

What this paper is about

Objective: To evaluate the protective effect of epidermal growth factor (EGF) on intestinal barrier functionin rats with acute pancreatitis. Methods: Thirty-two male SD rats received injection of sodium taurocholate solution(3. 5 mg·L-1) into the pancreatic duct were randomly divided into control group (n=16) and treatment group (n=16). Animals incontrol group received total parenteral nutrition (TPN), animals in treatment group were fed on the same TPN formula ascontrol group and injections of EGF at a dose of 0. 2 mg' kg l' day--'. Rats were sacrificed on d 1 and d 5 of TPN. Concen-tration of xylose and fluorescein isothiocyanate (FITC)-dextran in superior mesenteric vein (SMV), protein and DNA contentin je junal mucosa were determined. Samples from SMV, mesenteric lymph nodes, pancreas, liver, spleen were harvested forcultures. Results: FITC-dextran concentration in treatment group was significantly lower than in control group [(3. 4±0. 7)vs (7. 5±0. 9) mg. L-1, P<0. 0l]. Protein and DNA content in je junal mucosa in treatment group were significantly higherthan in control group [(2. 65±0. 23) vs (1. 12±0. 18) mg· cm-1, (0. 25±0. 07) vs (0. 12±0. 04) mg·cm-1, P0. 01].Positive cultures in liver and spleen in treatment group were significantly lower than in control group (37.5 % vs 100%, 25%vs 100%, P0.05). Conclusion: EGF may prevent the increase of intestinal permeability and bacterial translocation duringTPN in rats with acute pancreatitis.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective: To evaluate the protective effect of epidermal growth factor (EGF) on intestinal barrier functionin rats with acute pancreatitis. Methods: Thirty-two male SD rats received injection of sodium taurocholate solution(3. 5 mg·L-1) into the pancreatic duct were randomly divided into control group (n=16) and treatment group (n=16). Animals incontrol group received total parenteral nutrition (TPN), animals in treatment group were fed on the same TPN formula ascontrol group and injections of EGF at a dose of 0. 2 mg' kg l' day--'. Rats were sacrificed on d 1 and d 5 of TPN. Concen-tration of xylose and fluorescein isothiocyanate (FITC)-dextran in superior mesenteric vein (SMV), protein and DNA contentin je junal mucosa were determined. Samples from SMV, mesenteric lymph nodes, pancreas, liver, spleen were harvested forcultures. Results: FITC-dextran concentration in treatment group was significantly lower than in control group [(3. 4±0. 7)vs (7. 5±0. 9) mg. L-1, P<0. 0l]. Protein and DNA content in je junal mucosa in treatment group were significantly higherthan in control group [(2. 65±0. 23) vs (1. 12±0. 18) mg· cm-1, (0. 25±0. 07) vs (0. 12±0. 04) mg·cm-1, P0. 01].Positive cultures in liver and spleen in treatment group were significantly lower than in control group (37.5 % vs 100%, 25%vs 100%, P0.05). Conclusion: EGF may prevent the increase of intestinal permeability and bacterial translocation duringTPN in rats with acute pancreatitis.

Key concepts: Mesenteric lymph nodes, Acute pancreatitis, Spleen, Internal medicine, Epidermal growth factor, Pancreas, Fluorescein isothiocyanate, Pancreatitis

Related papers

Back to paper searchBrowse research topicsOriginal source
Epidermal growth factor prevents bacterial translocation in rats with acute pancreatitis — Research Paper | ScholarLens